The present invention relates to 5, 6, or7-substituted-3-(hetero)arylisoquinolinamine derivatives represented bygeneral formula D, their pharmacologically acceptable salts thereof,and compositions containing such compounds. Methods for treatinghyperproliferative disorders by administering the compounds are alsoincluded. Formula (I).